Royalty Pharma
RPRX
#625
Rank
ยฃ29.70 B
Marketcap
ยฃ51.67
Share price
-1.38%
Change (1 day)
72.15%
Change (1 year)

Royalty Pharma (RPRX) - Cash on Hand

Cash on Hand as of June 2026 : ยฃ1.31 Billion

According to Royalty Pharma's latest financial reports the company has ยฃ1.31 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Royalty Pharma - Cash on Hand chart (from 2019 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31ยฃ1.10 B-21.5%
2024-12-31ยฃ1.41 B45.73%
2023-12-31ยฃ0.96 B-51.74%
2022-12-31ยฃ2.00 B-3.37%
2021-12-31ยฃ2.07 B6.86%
2020-12-31ยฃ1.94 B221.29%
2019-12-31ยฃ0.60 B-67.82%
2018-12-31ยฃ1.87 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Abbott Laboratories
ABT
ยฃ5.56 B 322.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ3.72 B 182.95%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
ยฃ0.28 B-78.23%๐Ÿ‡บ๐Ÿ‡ธ USA